Stock Events

Stock Events

Edwards Lifesciences 

$100.40
297
-$1.11-1.09%Friday 08:57

Statistics

Day High
101.51
Day Low
100.4
52W High
101.51
52W Low
77
Volume
997
Avg. Volume
-
Mkt Cap
57.87B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Jan 27Expected
Q3 2025
Q1 2026
Q2 2026
Q3 2026
Next
0.6
0.66
0.73
0.8
Expected EPS
0.686166
Actual EPS
N/A

Financials

17.5%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
6.13BRevenue
1.07BNet Income

Analyst Ratings

$113.00Average Price Target
The highest estimate is ⁦120.00⁩.
From 13 ratings within the last 6 months. This is not an investment recommendation.
Buy
92%
Hold
8%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EW.BOATS. It's not an investment recommendation.
Apple
79
AAPL
Microsoft
73
MSFT
Alphabet
72
GOOGL
Amazon
70
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap123.49B
Medtronic competes directly with Edwards Lifesciences in the heart valve market, including transcatheter aortic valve replacement (TAVR) technologies.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific competes in the interventional cardiology space, offering products that rival Edwards Lifesciences' heart valve solutions.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories offers a range of cardiovascular devices, including mitral and tricuspid valve repair and replacement technologies that compete with Edwards' offerings.
Stryker
SYK
Mkt Cap111.95B
Stryker competes in the medical devices sector, including neurotechnology and spine products, which can be seen as indirect competition to Edwards Lifesciences' cardiovascular focus.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its medical devices segment, competes across various healthcare sectors, including cardiovascular, which puts it in competition with Edwards Lifesciences.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet, primarily known for orthopedics, has ventured into the cardiovascular space, positioning it as a competitor to Edwards Lifesciences.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical's robotic-assisted surgical systems can be used in cardiovascular surgeries, indirectly competing with Edwards Lifesciences' surgical heart valve solutions.
Edwards Lifesciences
EW
Mkt Cap53.03B
Edwards Lifesciences competes with itself through its diverse range of heart valve products, constantly innovating to replace its older technologies.
Baxter International
BAX
Mkt Cap11.9B
Baxter International competes in the broader medical devices market, including products for critical care, which can overlap with Edwards Lifesciences' cardiovascular focus.
Integra Lifesciences
IART
Mkt Cap991.6M
Integra LifeSciences, while more focused on neurosurgery and regenerative technologies, competes in the medical devices market, offering some products that can be used in cardiovascular procedures.

About

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Show More
CEO
ISIN
US28176E1082

Listings

STU
DE
EWL.STU
MU
DE
EWL.MU
MX
MX
EW.MX
LSE
GB
0REN.LSE

0 Comments

Share your thoughts

FAQs

What is Edwards Lifesciences stock price today?▼
The current price of EW.BOATS is $100.40 USD — it has decreased by -1.09% in the past 24 hours. Watch Edwards Lifesciences stock price performance more closely on the chart.
What is Edwards Lifesciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Edwards Lifesciences stocks are traded under the ticker EW.BOATS.
What is Edwards Lifesciences market cap?▼
Today Edwards Lifesciences has the market capitalization of 57.87B
When is the next Edwards Lifesciences earnings date?▼
Edwards Lifesciences is going to release the next earnings report on January 27, 2027.
What were Edwards Lifesciences earnings last quarter?▼
EW.BOATS earnings for the last quarter are 0.8 USD per share, whereas the estimation was 0.74 USD resulting in a +7.55% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Edwards Lifesciences revenue for the last year?▼
Edwards Lifesciences revenue for the last year amounts to 6.13B USD.
What is Edwards Lifesciences net income for the last year?▼
EW.BOATS net income for the last year is 1.07B USD.
In which sector is Edwards Lifesciences located?▼
Edwards Lifesciences operates in the Other sector.
When did Edwards Lifesciences complete a stock split?▼
The last stock split for Edwards Lifesciences was on June 1, 2020 with a ratio of 3:1.